StageAcquired | Acquired
About Astute Medical
Astute Medical is dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel in vitro diagnostic tests. Its focus is community and hospital acquired acute conditions that require rapid diagnosis and risk assessment.
Missing: Astute Medical's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Astute Medical's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Astute Medical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Astute Medical is included in 3 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Astute Medical Patents
Astute Medical has filed 102 patents.
The 3 most popular patent topics include:
- Kidney diseases
- Rare diseases
Kidney diseases, Nephrology, Vascular diseases, Rare diseases, Inflammations
Kidney diseases, Nephrology, Vascular diseases, Rare diseases, Inflammations
Latest Astute Medical News
May 22, 2023
News Provided By Share This Article Renal Biomarkers Market Trend BURLINGAME, CALIFORNIA, UNITED STATES, May 22, 2023 / EINPresswire.com / -- The Global Renal Biomarkers Market is estimated to account for US$ 1,094.5 Mn in terms of value in 2023 and is expected to reach US$ 1,894.2 Mn by the end of 2030. “Renal Biomarkers Market” is a valuable source of insightful data for developing business strategies. It provides the industry overview with growth analysis and historical and futuristic cost, revenue, demand, and supply data. The research analysts provide a detailed description of the value chain and its distributor analysis. This research provides comprehended Renal Biomarkers data that enhances the understanding, scope and application of this report. Renal Biomarkers Market Provides a Depth-Analysis of the Latest Developments, Market Size, Share, upcoming technologies, challenges, opportunities, and regulatory policies, with key company profiles and strategies of key players. Renal Biomarkers Market 2023-2030 is collected with help of various research tools like SWOT analysis, PESTLE analysis, and Poster’s Five Forces analysis. Combined with important market challenges, the potential of this industry field has been fully explored. The current market conditions and prospects of this segment have also been checked. In addition, key market strategies including product development, partnerships, mergers, and acquisitions will also be studied. Upstream resources and downstream demand analysis are also conducted. Get Exclusive Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/3551 Note – Updated Version 2023 is available Our Sample Report May Includes: ‣ 2030 Updated Report Introduction, Overview, and In-depth industry analysis. ‣ 100+ Pages Research Report (Inclusion of Updated Research). ‣ Provide Chapter-wise guidance on Requests. ‣ 2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends ‣ Includes Updated List of tables & figures. ‣ Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis. The Major Players Profiled in this Report include Beckman Coulter, Inc., (Danaher Corporation), Thermo Fisher Scientific Inc., Abbott Laboratories, BIOPORTO A/S, Astute Medical, Inc., Randox Laboratories Ltd., and SphingoTec GmbH. Market Insights of The Market Report The market research report offers a detailed market analysis which contains the future forecast with an acceptable set of prediction, previous data, scientific analysis, thoughtful findings, scientifically-rich information and industry oriented methodology. Apart from this, it contains details like market segments, distribution types, application categories, countries, and products. The market is further segmented by Global Renal Biomarkers Market, By Biomarker Type: Functional Biomarker (Serum Creatinine, Serum Cystatin C, Urine Albumin) Up-Regulated Proteins (Neutrophil gelatinase-associated lipocalin, Kidney injury molecule 1, Interleukin 18) Others Enzyme Linked Immunosorbent Assay ➤ North America (United States, Canada, and Mexico) ➤ Europe (UK, Germany, France, Russia, and Italy) ➤ Asia-Pacific (China, Korea, Japan, India, and Southeast Asia) ➤ South America (Brazil, Colombia, Argentina, etc.) ➤ The Middle East and Africa (Saudi Arabia, UAE, Nigeria, Egypt, and South Africa) What are the Factors Restraining Demand for Renal Biomarkers Industry? ☛ GTM strategy ☛ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer) ☛ Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, CMI ☛ quadrant, and other significant analysis, as well as development status ☛ Recent market developments and it’s futuristic growth opportunities ☛ Customized regional/country reports as per request Direct Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/3551 BUSINESS STRATEGY In this report, key strategies of the Renal Biomarkers market are analysed such as product developments, partnerships, mergers and acquisitions, etc. The value of strategic analysis has been scrutinized with clear market challenges. The Renal Biomarkers Market report provides a conclusion including analysis and data triangulation, changing consumer needs/customer preferences, research findings, market size estimation, data sources. These factors will increase your overall business. DRIVERS & RESTRAINTS The report includes a value chain analysis for each product segment. Value chain analysis provides detailed information on value addition at each stage. The research contains drivers and restraints for the Renal Biomarkers Market, as well as their impact on demand throughout the forecast period. The analysis also includes critical market variables that influence market growth. Covid-19 the pandemic has had a significant influence on the supply chain, and a thorough examination of the market impact is provided in the research report. MARKET DYNAMICS The research gives High-quality Renal Biomarkers Market Dynamics, which includes industry growth drivers, challenges, opportunities, risk, restrictions, and threats. Manufacturing Cost Analysis is also covered in the reports, which primarily contains Product Price Trends, Mergers & Acquisitions, Expansion, Key Suppliers of Product, Concentration Rate of Renal Biomarkers Market, and Manufacturing Process Analysis. The research report analyses market effect factors such as technological progress, consumer needs trends, and external environmental change. The research study has worked extensively on supply-demand analysis, which has become an important parameter in the industry. Supplier analysis aids in understanding the supply-demand dynamic, which in turn aids in the creation of a better manufacturing process. Porter’s 5 Forces model, PESTLE analysis, SWOT analysis, and market sizing are among the analytical tools utilized in the development of research projects. Because of the dynamic nature of the opportunity and threat analysis has grown in relevance in recent years. Purchasing the Renal Biomarkers Market for the Following Reasons: 👉 The research would help top administration/policymakers/professionals/product advancements/sales managers and stakeholders in this market in the following ways. 👉 The report provides Renal Biomarkers Market revenues at the worldwide, regional, and country levels with a complete analysis to 2030 permitting companies to analyse their market share and analyse projections, and find new markets to aim for. 👉 To understand the most affecting driving and restraining forces in the market and their impact on the worldwide market. 👉 Major changes and assessment in market dynamics and developments. 👉 The objective of the Renal Biomarkers Market report is to identify new business opportunities using quantitative market forecasts. 👉 Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses FAQ’s ☛ What is the size of the market in terms of revenue, sales volume, or number of users/customers? ☛ Who are the key players in the market, and what are their market shares? ☛ What are the trends and drivers shaping the market, and what are the challenges and opportunities? ☛ What are the different segments of the market, and how are they expected to grow? ☛ What are the key products or services offered in the market, and how do they compare to each other? ☛ What are the pricing strategies and competitive landscape of the market? ☛ What are the regulatory and legal factors affecting the market? ☛ What are the marketing and promotional strategies used by companies in the market? ☛ What are the customer preferences and buying behaviors in the market? ☛ What are the future prospects and growth potential of the market? Request for Enquiry or Customization: https://www.coherentmarketinsights.com/insight/request-customization/3551 About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients. Mr. Shah +1 206-701-6702
Astute Medical Frequently Asked Questions (FAQ)
When was Astute Medical founded?
Astute Medical was founded in 2007.
Where is Astute Medical's headquarters?
Astute Medical's headquarters is located at 3550 General Atomics Court, San Diego.
What is Astute Medical's latest funding round?
Astute Medical's latest funding round is Acquired.
How much did Astute Medical raise?
Astute Medical raised a total of $174.16M.
Who are the investors of Astute Medical?
Investors of Astute Medical include bioMerieux, Bio-Techne, Fosun Pharmaceutical, Ortho Clinical Diagnostics, De Novo Ventures and 7 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.